Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-28

Clinical Trial Update: Evaluation of the Efficacy of Oral Immunotherapy with Raw Apple in Patients Allergic to Birch Pollen and Apple: Prospective, Multicenter, Comparative Phase III Study [Phase 3]

View source ↗

Summary

A Phase 3 multicenter trial is evaluating the efficacy of raw-apple oral immunotherapy for individuals with birch pollen allergy and apple allergy; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raw Apple Oral Immunotherapy

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Allergies | Phase 3 | Status: RECRUITING